Medifast, Inc. (MED) Tops Q4 EPS by 3c; Issues Mixed Outlook
Medifast, Inc. (NYSE: MED) reported Q4 EPS of $0.28, $0.03 better than the analyst estimate of $0.25. Revenue for the quarter came in at $83.2 million versus the consensus estimate of $82.9 million.
Medifast, Inc. sees Q1 2013 EPS of $0.32-0.35, versus the consensus of $0.45. Medifast, Inc. sees Q1 2013 revenue of $93-95 million, versus the consensus of $101.13 million.
Medifast, Inc. sees FY2013 EPS of $1.70-1.80, versus the consensus of $1.76. Medifast, Inc. sees FY2013 revenue of $385-400 million, versus the consensus of $399.6 million.
For earnings history and earnings-related data on Medifast, Inc. (MED) click here.
Medifast, Inc. sees Q1 2013 EPS of $0.32-0.35, versus the consensus of $0.45. Medifast, Inc. sees Q1 2013 revenue of $93-95 million, versus the consensus of $101.13 million.
Medifast, Inc. sees FY2013 EPS of $1.70-1.80, versus the consensus of $1.76. Medifast, Inc. sees FY2013 revenue of $385-400 million, versus the consensus of $399.6 million.
For earnings history and earnings-related data on Medifast, Inc. (MED) click here.